Bio Green Med Solution Business Summary

Bio Green Med Solution, Inc. (BGMS) operates a diversified business model that generates revenue through the distribution, trading, and installation of fire safety equipment and prevention systems, alongside legacy biopharmaceutical research. Following its strategic acquisition of Fitters Sdn. Bhd. in late 2025, the company’s primary business segments are Fire Protection—offering products such as fire extinguishers, foam systems, and fire-resistant doors—and Biopharmaceuticals, which focuses on oncology therapeutics like fadraciclib. BGMS competes directly with small-cap biotech and safety firms such as Decoy Therapeutics, Shuttle Pharmaceuticals, and Silo Pharma. Positioned as a turnaround play, the company is currently transitioning from a pure-play clinical-stage biopharmaceutical entity into a commercial-scale diversified industrial group with a concentrated focus on the Southeast Asian fire safety market. Originally founded in 1996 by Ronald J. Berenson, David Philip Lane, and David Glover, the company is now led by a new executive team following its 2025 corporate pivot. Datuk Dr. Doris Wong Sing Ee serves as the Chief Executive Officer and Executive Director, bringing a background in medical management and leadership roles at ARC Group and Trive Property Group. The financial operations are overseen by Kiu Cu Seng, who serves as Chief Financial Officer and Executive Director. The board of directors includes independent members such as Soon Ping Zara Pappas, Inigo Angel Laurduraj, and Dr. Satis Waran Nair Krishnan. Notable institutional support and investment have historically involved Armistice Capital Master Fund Ltd. and Helena Special Opportunities 1 Ltd., reflecting a shareholder base focused on the company's recent diversification strategy.